Home/Filings/4/0001209191-21-025842
4//SEC Filing

Michelon Francois Roger 4

Accession 0001209191-21-025842

CIK 0001681682other

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 4:05 PM ET

Size

5.4 KB

Accession

0001209191-21-025842

Insider Transaction Report

Form 4
Period: 2021-04-05
Michelon Francois Roger
DirectorChief Executive Officer
Transactions
  • Award

    Stock Options

    2021-04-05+50,00050,000 total
    Exercise: $2.64Exp: 2031-04-05Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]This stock option grant becomes exercisable in three equal annual installments beginning April 5, 2022.

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1
  • filerCIK 0001691470

Filing Metadata

Form type
4
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 4:05 PM ET
Size
5.4 KB